- Home
- ZYME vs FLNC Comparison
ZYME vs FLNC Comparison
Compare ZYME & FLNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- FLNC
- Stock Information
- Founded
- ZYME 2003
- FLNC 2018
- Country
- ZYME United States
- FLNC United States
- Employees
- ZYME N/A
- FLNC N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- FLNC Industrial Machinery/Components
- Sector
- ZYME Health Care
- FLNC Miscellaneous
- Exchange
- ZYME Nasdaq
- FLNC Nasdaq
- Market Cap
- ZYME 867.6M
- FLNC 802.6M
- IPO Year
- ZYME 2017
- FLNC 2021
- Fundamental
- Price
- ZYME $13.30
- FLNC $7.94
- Analyst Decision
- ZYME Buy
- FLNC Hold
- Analyst Count
- ZYME 7
- FLNC 18
- Target Price
- ZYME $19.50
- FLNC $8.81
- AVG Volume (30 Days)
- ZYME 494.5K
- FLNC 6.3M
- Earning Date
- ZYME 07-31-2025
- FLNC 08-06-2025
- Dividend Yield
- ZYME N/A
- FLNC N/A
- EPS Growth
- ZYME N/A
- FLNC N/A
- EPS
- ZYME N/A
- FLNC N/A
- Revenue
- ZYME $93,384,000.00
- FLNC $2,329,871,000.00
- Revenue This Year
- ZYME $44.71
- FLNC $2.61
- Revenue Next Year
- ZYME $34.57
- FLNC $27.01
- P/E Ratio
- ZYME N/A
- FLNC N/A
- Revenue Growth
- ZYME 85.05
- FLNC 6.08
- 52 Week Low
- ZYME $9.03
- FLNC $3.46
- 52 Week High
- ZYME $17.70
- FLNC $24.00
- Technical
- Relative Strength Index (RSI)
- ZYME 61.39
- FLNC 65.19
- Support Level
- ZYME $12.75
- FLNC $6.06
- Resistance Level
- ZYME $13.80
- FLNC $8.92
- Average True Range (ATR)
- ZYME 0.42
- FLNC 0.59
- MACD
- ZYME 0.07
- FLNC 0.11
- Stochastic Oscillator
- ZYME 79.88
- FLNC 70.32
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About FLNC Fluence Energy Inc.
Fluence Energy Inc is enabling the global clean energy transition with market-leading energy storage products and services, and digital applications for renewables and storage. Geographically, it derives a majority of its revenue from the Americas.